Arginine therapy for acute myocardial infarction [9]

JAMA

Volumn 295, Issue 18, 2006, Pages 2138-2139

  Abumrad, Naji N ^a   Barbul, Adrian ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; NITRIC OXIDE; ORNITHINE;

ACUTE HEART INFARCTION; DRUG BLOOD LEVEL; HEART ARRHYTHMIA; HEART RUPTURE; HUMAN; HYPERKALEMIA; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPSIS; ST SEGMENT ELEVATION; SUPPLEMENTATION; HEART INFARCTION; NOTE;

ARGININE; HUMANS; MYOCARDIAL INFARCTION;

EID: 33646457071     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.295.18.2138-b     Document Type: Letter

References (6)

1. Schulman SP, Becker LC, Kass DA, et al. L-Arginine therapy in acute myocardial infarction: the Vascular Interaction with Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA. 2006;295:58-64.
2. Sternberg EM. Pathogenesis of L-tryptophan eosinophilia myalgia syndrome. Adv Exp Med Biol. 1996;398:325-330.
3. Bushinsky DA, Gennari FJ. Life-threatening hyperkalemia induced by arginine. Ann Intern Med. 1978;89(5 pt 1):632-634.
4. Massara F, Martelli S, Cagliero E, et al. The hypophosphatemic and hyperkalemic effect of arginine in man. J Endocrinol Invest. 1980;3:177-180.
5. Efron DT, Barbul A. Modulation of inflammation and immunity by arginine supplements. Curr Opin Clin Nutr Metab Care. 1998;1:531-538.
6. Luiking YC, Poeze M, Ramsay G, Deutz NE. The role of arginine in infection and sepsis. JPEN J Parenter Enteral Nutr. 2005;29(1 suppl):S70-S74.